eiCHO

2-10x Productivity Improvement for Soluble Biologics

  • Faster and cheaper to the clinic, even for vanilla IgGs.

  • High titer for new modalities like multi-specifics and fusion proteins.

  • Reduced cost of manufacturing to bring biosimilars to more patients

The Triplebar SolutionThe size and scale of our data powers BioAI, changing the way we design biology

We generate this data by vastly increasing the throughput of test.  We miniaturize the unit of test in biology, the “test tube” into a picoliter volume microreactor. Through miniaturization, we can evaluate 10Ms microbes for high-volume protein production in a single day. We then index and sequence the top 0.1%, building vast data sets of phenotypically labeled genomes. 

Screen 10M+ cells/day for Protein TiTer
AND sequence the 0.1% that are better